JAMP LAMIVUDINE / ZIDOVUDINE
Identification of Jamp Lamivudine / Zidovudine
| No description |
Google image searchProduct monograph
Active ingredients
zidovudine, 300 MG
lamivudine, 150 MG
DIN: 02502801
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 14-MAR-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR01 — ZIDOVUDINE AND LAMIVUDINE (ATC/DDD)
Reference brand drug: Combivir
Pharmaceutical standard: USP
